Petros Pharmaceuticals, Inc. files current report with SEC

Petros Pharmaceuticals, Inc. filed an 8-K covering SEC Item 1.03, a triggering event affecting a financial obligation, and director or executive-officer changes. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.